Skip to content Skip to footer

Alzheimer’s Disease Clinical Trials

See if you or a loved one qualifies today!

Memory Loss Disrupting Daily Life?

Explore Alzheimer’s Disease Clinical Trials That May Potentially Help Regain Control.

Alzheimer’s disease is a progressive neurological condition that impacts memory, thinking, and behavior. While age remains the primary risk factor, genetics, environment, and lifestyle also play a role in its development.

An estimated 6.9 million Americans are living with Alzheimer’s, and this number is expected to rise dramatically in the coming years. The disease not only affects the individual but also places emotional and financial strain on caregivers and loved ones.

If you or someone close to you has been diagnosed with Alzheimer’s disease, Revival Research Institute is conducting Alzheimer’s Disease Clinical Trial. This clinical trial is being conducted to intervene in Alzheimer’s onset in its earlier stages and stop it from progressing to clinical stages.

Is Alzheimer’s Disease Clinical Trials A Fit for You?

To qualify for the Alzheimer’s Disease Clinical Trials currently enrolling, participants must meet the following criteria:

*Additional criteria may apply.

Participation in our Alzheimer’s Disease Clinical Trials includes access to study-related care, health assessments, investigational medication, and regular monitoring, completely free of charge, with no insurance required.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
This is our Privacy Policy.

About the Alzheimer’s Disease Clinical Trials

Alzheimer’s disease is a progressive neurological condition that gradually impairs memory, thinking, and daily functioning. As symptoms worsen over time, individuals may experience confusion, difficulty completing familiar tasks, and emotional changes—deeply affecting both patients and their loved ones.

Alzheimer’s Disease Clinical Trials are being conducted at multiple locations across the United States to explore potential new treatment options that may slow the progression of the disease or improve cognitive function. These research efforts are focused on understanding how Alzheimer’s develops and how to better manage its symptoms.

Many of these trials are investigating how the buildup of certain proteins in the brain (such as amyloid plaques) may contribute to memory loss and cognitive decline. The investigational treatments being studied are designed to target these proteins, with the goal of preserving brain function and delaying disease progression.

By joining an Alzheimer’s disease clinical trial, you can contribute to research that may lead to new breakthroughs and offer hope for future treatment options.

*All study procedures and study-related treatments, including the investigational drug, are provided at no cost, and no insurance is required to participate. Participants may receive compensation for time and travel.

*To take the next step, submit the form above, and our research staff will contact you to determine if you qualify for the study. There may be a brief discussion about your health and medical history.

Get Started
What to Expect?

If you are living with Alzheimer’s disease, you may qualify for a paid clinical trial exploring new treatment options. After submitting the interest form above, a member of our research team will contact you for a brief pre-screening to determine whether you meet the initial eligibility criteria. If you qualify, you will be asked to review and sign an Informed Consent Form (ICF), which outlines all study procedures, potential benefits, and risks.

Once consent is given, you will be invited to a screening visit at one of our clinical research sites. During this visit, we’ll review your medical history, conduct a physical examination, and perform lab tests to further assess your eligibility.

All study-related care is provided at no cost, and no insurance is required. Participants must also have a reliable study partner—someone who can attend study visits with them and help report any changes in health or behavior throughout the trial.

Our dedicated research team will ensure you fully understand your role in the study and what to expect every step of the way. You are encouraged to ask any questions before deciding to participate. By taking part, you’re contributing to important research that may lead to future advances in the treatment of Alzheimer’s disease.

Age Icon
Age
55 – 80 years
Condition Icon
Condition
Alzheimer’s Disease
Location Icon
Location
Michigan

Struggling with Alzheimer’s Disease?

Alzheimer’s disease is a progressive, degenerative brain disorder that gradually destroys memory, thinking ability, and the capacity to perform everyday tasks. It commonly affects older adults and begins with mild memory loss, eventually advancing to confusion, disorientation, and loss of independence. Over time, the disease can impair speech, judgment, and motor skills, significantly altering day-to-day functioning.

For many, Alzheimer’s disease deeply impacts both the individual and their caregivers, often leading to emotional strain, caregiver burnout, and significant changes in family dynamics.

The exact cause of Alzheimer’s remains unclear, but the condition is strongly linked to abnormal protein buildup in the brain, including amyloid plaques and tau tangles. These disrupt communication between neurons and lead to brain cell death. Aging, genetics, and lifestyle factors contribute to disease progression.

Alzheimer’s Disease May Be Triggered By

Common Symptoms of Alzheimer’s Disease

Frequently Asked Questions

Helping You Make Informed Decisions

Living with Alzheimer’s disease can be challenging, and it’s natural to have questions. We’ve compiled answers to some of the most frequently asked questions about the condition, its symptoms, triggers, and everyday management, to help you feel more informed and supported. Looking for more guidance? Reach out to our amazing team: +1 (248) 721-9539

Alzheimer's is a progressive brain disorder that leads to memory loss, confusion, language issues, and behavioral changes. It interferes with independence, requiring increasing levels of care over time.

While the exact cause is still unknown, Alzheimer’s is believed to result from a combination of genetic, lifestyle, and environmental factors that damage and kill brain cells over time.

This trial provides early access to investigational treatments and close medical monitoring. Participation may benefit not just you but also future generations by advancing medical science.

Early-onset Alzheimer’s occurs in people younger than 65, often in their 40s or 50s. It is less common but can be especially challenging due to work, family, and lifestyle disruptions. The symptoms are similar to those of later-onset Alzheimer’s.

A study partner is a person who knows you well and would notice any changes in your memory, mood, and behavior. This could be your spouse, partner, friend, family member, or someone whose job it is to help you.